Levetiracetam Rivopharm 250

Levetiracetam Rivopharm 250 is a medicine authorised by Swissmedic under authorisation number 62036. The authorisation holder is Rivopharm SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 March 2012 and the authorisation is valid without a time limit. ATC code N03AX14 places the medicine in the group Antiepileptics.

  • Dispensing category B
  • Authorisation number 62036
  • ATC N03AX14
  • Synthetic medicines
Authorisation data
Authorisation number62036
NameLevetiracetam Rivopharm 250
Full nameLevetiracetam Rivopharm 250, compresse rivestite con film
Authorisation holderRivopharm SA
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeN03AX14
First authorisation21 March 2012
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Levetiracetam Rivopharm 250, compresse rivestite con filmB21 March 2012
2Levetiracetam Rivopharm 500, compresse rivestite con filmB21 March 2012
4Levetiracetam Rivopharm 1000, compresse rivestite con filmB21 March 2012

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
830Tablette(n)N03AX1401.07.1.B
920Tablette(n)N03AX1401.07.1.B
10100Tablette(n)N03AX1401.07.1.B
11200Tablette(n)N03AX1401.07.1.B
1230Tablette(n)N03AX1401.07.1.B
13100Tablette(n)N03AX1401.07.1.B
14200Tablette(n)N03AX1401.07.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Levetiracetam Rivopharm 250 authorised in Switzerland?

Yes. Levetiracetam Rivopharm 250 is authorised by Swissmedic under authorisation number 62036, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Levetiracetam Rivopharm 250 have?

Levetiracetam Rivopharm 250 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Levetiracetam Rivopharm 250?

The authorisation holder is Rivopharm SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com